Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Nov 18:5:625.
doi: 10.3389/fmicb.2014.00625. eCollection 2014.

Antibody and B cell responses to Plasmodium sporozoites

Affiliations
Review

Antibody and B cell responses to Plasmodium sporozoites

Johanna N Dups et al. Front Microbiol. .

Abstract

Antibodies are capable of blocking infection of the liver by Plasmodium sporozoites. Accordingly the induction of anti-sporozoite antibodies is a major aim of various vaccine approaches to malaria. In recent years our knowledge of the specificity and quantities of antibodies required for protection has been greatly expanded by clinical trials of various whole sporozoite and subunit vaccines. Moreover, the development of humanized mouse models and transgenic parasites have also aided our ability to assess the specificity of antibodies and their ability to block infection. Nonetheless, considerable gaps remain in our knowledge - in particular in understanding what antigens are recognized by infection blocking antibodies and in knowing how we can induce robust, long-lived antibody responses. Maintaining high levels of circulating antibodies is likely to be of primary importance, as antibodies must block infection in the short time it takes for sporozoites to reach the liver from the skin. It is clear that a better understanding of the development of protective B cell-mediated immunity will aid the development and refinement of malaria vaccines.

Keywords: B cells; Plasmodium; antibodies; malaria; pre-erythrocytic stages; sporozoites.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
The development of memory B cell subsets. Upon encounter with either sporozoite antigen or vaccines, naïve B cells can undergo a variety of different fates. Some develop into short-lived plasmablasts, which give an immediate antibody response to infection. Others may become “early memory” which is germinal center independent, or may enter germinal centers where theirB cell receptors undergo somatic hypermutation and affinity maturation. The germinal center B cells are believed to be the major precursors for long-lived plasma cells, which maintain the circulating antibody pool. Memory cells may be class switched or they may retain the IgM+ B cell receptor. The relative contributions of these different memory populations to long term protection against malaria remains an area for further investigation. Figure is based on Taylor et al. (2012). Used with permission from Elsevier.

References

    1. Agnandji S. T., Fendel R., Mestre M., Janssens M., Vekemans J., Held J., et al. (2011a). Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01E and RTS,S/AS02D. PLoS ONE 6:e18559 10.1371/journal.pone.0018559 - DOI - PMC - PubMed
    1. Agnandji S. T., Lell B., Soulanoudjingar S. S., Fernandes J. F., Abossolo B. P., Conzelmann C., et al. (2011b). First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365 1863–1875 10.1056/NEJMoa1102287 - DOI - PubMed
    1. Amino R., Thiberge S., Martin B., Celli S., Shorte S., Frischknecht F., et al. (2006). Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12 220–224 10.1038/nm1350 - DOI - PubMed
    1. Behet M. C., Foquet L., Van Gemert G. J., Bijker E. M., Meuleman P., Leroux-Roels G., et al. (2014). Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum. Malar. J. 13 136 10.1186/1475-2875-13-136 - DOI - PMC - PubMed
    1. Bongfen S. E., Ntsama P. M., Offner S., Smith T., Felger I., Tanner M., et al. (2009). The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity. Vaccine 27 328–335 10.1016/j.vaccine.2008.09.097 - DOI - PubMed

LinkOut - more resources